Pfizer Recalls Another Blood Pressure Medication

April 25, 2022

The pharmaceutical institution Pfizer has voluntary recalled a humor unit medicine for the 2nd clip successful a month.

Pfizer is recalling 5 tons of humor unit medicine Accupril due to the fact that of elevated levels of a nitrosamine, Nnitroso-quinapril, the institution said successful a news release posted Friday connected the FDA website.

Nitrosamines are recovered successful h2o and foods, including grilled meats and dairy products, but impurities whitethorn summation a person’s crab hazard implicit agelong periods of time, Pfizer said.

Accupril is utilized to little humor unit and negociate bosom failure. Pfizer said it has not received immoderate reports of adverse reactions by radical taking the drug.

“Pfizer believes the benefit/risk illustration of the products remains affirmative based connected presently disposable data. Although semipermanent ingestion of Nnitroso-quinapril whitethorn beryllium associated with a imaginable accrued crab hazard successful humans, determination is nary contiguous hazard to patients taking this medication,” the institution said.

The Accupril tables are sold successful 10-, 20- and 40-mg doses. The affected batch numbers are DR9639, DX8682, DG1188, DX6031, and CK6260.

Patients taking the merchandise should speech to their doctor. Patients with the affected merchandise should telephone 888-345-0481.

Pfizer recalled different humor unit medicine connected March 22.

The affected products successful that recall are quinapril HCl/hydrochlorothiazide (Accuretic) tablets that Pfizer distributes, and 2 authorized generics, quinapril positive hydrochlorothiazide and quinapril HCl/hydrochlorothiazide, distributed by Greenstone. The callback is implicit higher than accepted levels of N-nitroso-quinapril, a compound known arsenic a nitrosamine.